USPTO serial 99479541
MEDITAG
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- HOPKINS II, DEAN ANDREW
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with MEDITAG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*
Plus Government fees of $600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Carrie Webb Olson
Carrie Webb Olson Day Pitney LLPOne Federal Street, 29th FloorBoston, MA 02110United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for tracking, monitoring, analyzing, and managing prescription and over-the-counter drugs; downloadable software for recording and analyzing the quantity and consumption of prescription and over-the-counter drugs; downloadable software for sending reminders and notifications related to prescription and over-the-counter drug schedules, refills, and dosage compliance; downloadable software in the nature of a mobile application for tracking, monitoring, and managing prescription and over-the-counter drug usage, recording and analyzing the quantity and consumption of prescription and over-the-counter drugs, and for sending reminders and notifications related to prescription and over-the-counter drug schedules, refills, and dosage compliance | ACTIVE | — |
| 010 | Medical device for tracking, analyzing, monitoring, and checking prescription and over-the-counter drugs usage and consumption, adherence to prescription and over-the-counter drug regimens, detecting non-compliance with prescription and over-the-counter drug regimens, and alerting users to non-compliance to prescription and over-the-counter drug regimens; medical apparatus for assisting patients in adhering to prescription and over-the-counter drug regimens; dosage dispensers for administering prescription and over-the-counter drugs | ACTIVE | — |
| 042 | Providing temporary use of non-downloadable software for tracking, monitoring, and managing prescription and over-the-counter drug usage; providing temporary use of non-downloadable software for recording and analyzing the quantity and consumption of prescription and over-the-counter drugs; providing a web-based platform in the nature of a non-downloadable web application featuring technology that enables for users to manage prescription and over-the-counter drug schedules, monitor adherence, and track inventory of pharmaceutical products; research and development of pharmaceutical preparations, prescription and over-the-counter drugs; medical and scientific research in the fields of pharmaceuticals, prescription and over-the-counter drugs, and therapeutics; consulting services in the fields of pharmaceutical research and development | ACTIVE | — |
| 044 | Providing information in the field of health and wellness via a website | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Aquestive Therapeutics, Inc.
- Other trademarks owned by Aquestive Therapeutics, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MEDITAG
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 7, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 6, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 6, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 6, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 16, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 21, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 21, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 15, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 25, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 25, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 25, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 25, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 25, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 24, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 17, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 12, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 4, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 4, 2025 | NWAP | NEW APPLICATION ENTERED | — |